AI-CVD vs CT Cardiomegaly

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI-CVD

by HeartLung AI

CT Cardiomegaly

by Innolitics

AI Verdict

Tool A (AI-CVD) is a comprehensive platform for opportunistic screening of cardiovascular and multisystem diseases, offering a broad range of measurements including cardiac chamber volumetry. Tool B (CT Cardiomegaly) is a specialized command-line tool focused specifically on automatically measuring the cardiothoracic ratio from CT images for cardiomegaly detection. While both utilize AI on CT scans for cardiac assessment, Tool A provides a wider array of analyses, whereas Tool B offers a highly targeted solution for a specific cardiac measurement.

Choose AI-CVD if…

Choose AI-CVD if your organization seeks a comprehensive, opportunistic screening solution to identify a wide array of hidden cardiovascular and multisystem disease risks from existing CT scans. This platform is ideal for leveraging routine chest and abdominal CTs to automatically assess coronary artery calcium, cardiac chamber volumes, epicardial fat, and aortic/pulmonary artery sizing without additional imaging or workflow disruption. It's best suited for proactive detection of multiple risk factors beyond just cardiomegaly.

View AI-CVD →

Choose CT Cardiomegaly if…

Choose CT Cardiomegaly if your primary need is a precise, automated measurement of the cardiothoracic ratio from CT chest images for the specific purpose of cardiomegaly detection. This command-line software is well-suited for integration into existing radiology workflows where a quantitative, objective assessment of heart enlargement based on CTR is desired, providing clear PDF and JSON reports. It's ideal for focused analysis of cardiomegaly rather than broad cardiovascular risk screening.

View CT Cardiomegaly →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AI-CVD	CT Cardiomegaly
Pricing	Unknown	Contact for pricing
Deployment	Unknown	Docker Container (Ubuntu 20.04), command-line software
FDA Status	Unknown	Yes AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AI-CVD

AI-CVD is described as a 'quantitative imaging platform' with cloud deployment and emphasizes 'no additional workflow disruption,' suggesting a user-friendly interface and seamless integration into clinical settings. In contrast, CT Cardiomegaly is a 'command-line software' deployed via Docker, which typically requires more technical expertise and is less intuitive for direct clinical users.

Clinical Value

AI-CVD

AI-CVD offers comprehensive opportunistic screening for a wide range of cardiovascular and multisystem diseases, including CAC scoring, cardiac chamber volumetry, and analysis of aortic/mitral valve calcium, bone mineral density, and liver attenuation from existing CT scans. CT Cardiomegaly, while valuable, focuses on the single measurement of cardiothoracic ratio for cardiomegaly detection, providing a narrower scope of clinical insights.

Pricing & Value

AI-CVD

Both tools require direct contact for pricing, making a direct cost comparison impossible. However, AI-CVD's extensive suite of features for comprehensive opportunistic screening across multiple cardiovascular and multisystem diseases likely offers greater overall value by maximizing the insights extracted from existing CT scans.

Enterprise Readiness

CT Cardiomegaly

Both tools are FDA-cleared and offer enterprise-friendly deployment options (Cloud for AI-CVD, Docker for CT Cardiomegaly). However, CT Cardiomegaly explicitly states 'yes' for HIPAA compliance and BAA, providing a clearer assurance for enterprise data security and regulatory requirements compared to AI-CVD's 'likely, contact vendor' statement.

Innovation

AI-CVD

AI-CVD demonstrates greater innovation by providing a comprehensive, opportunistic screening platform that extracts a wide range of cardiovascular and multisystem disease markers from existing CT scans, significantly expanding the utility of routine imaging for preventive medicine. CT Cardiomegaly, while effective, applies AI to a more focused task of cardiothoracic ratio measurement.

Support & Docs

CT Cardiomegaly

Innolitics, the developer of CT Cardiomegaly, publicly showcases its expertise in technical documentation and open-source tools, including a DICOM Standard Browser and various open-source DICOM libraries. This suggests a strong commitment to providing accessible technical information and support for its command-line software.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AI-CVD	CT Cardiomegaly
Name	AI-CVD	CT Cardiomegaly
Company	HeartLung Corporation	Innolitics
Primary Use Case	Opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks.	Automatically measures cardiothoracic ratio from CT chest images, assisting physicians in cardiomegaly detection with quantitative data.
Key Measurements/Screening	Coronary Artery Calcium (CAC) scoring, Aortic wall/valve/mitral valve calcium analysis, Cardiac chamber volumetry (Left Atrium, Left Ventricle, Right Atrium, Right Ventricle), Epicardial fat volumetry, Aorta and pulmonary artery sizing.	Automatic cardiothoracic ratio measurement (linear and area-based), Segmentation of heart and thoracic cavity.
Output Formats	Not specified	PDF and JSON reports
Workflow Integration/Impact	No additional imaging, radiation, contrast, or workflow disruption.	Command-line software tool.

Videos

Demos, reviews, and walkthroughs featuring AI-CVD and CT Cardiomegaly.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific cardiovascular measurements do these tools provide?

AI-CVD offers a broad range of automated CT-derived measurements, including Coronary Artery Calcium (CAC) scoring, aortic and mitral valve calcium analysis, cardiac chamber volumetry, epicardial fat volumetry, and aorta and pulmonary artery sizing. In contrast, CT Cardiomegaly focuses specifically on automatically measuring linear and area-based cardiothoracic ratios from CT chest images.

What is the primary clinical application or screening focus of each tool?

AI-CVD is designed for opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, aiming for early detection of hidden health risks. CT Cardiomegaly assists physicians in cardiomegaly detection by providing quantitative cardiothoracic ratio measurements from CT chest images.

What types of CT scans are compatible with each tool for analysis?

AI-CVD performs opportunistic screening using existing chest and abdominal CT scans. CT Cardiomegaly is specifically designed to measure cardiothoracic ratio from CT chest images.

How do these tools integrate into an existing clinical workflow?

AI-CVD is designed to integrate without additional imaging, radiation, contrast, or workflow disruption, leveraging existing CT scans for opportunistic screening. CT Cardiomegaly is a command-line software tool that outputs PDF and JSON reports, suggesting integration into a system that can execute such tools and process these report formats.

What are the output formats for the analytical results from each tool?

While AI-CVD is described as a quantitative imaging platform providing automated measurements, specific output formats like reports or images are not detailed in the provided information. CT Cardiomegaly explicitly states that it outputs results in PDF and JSON reports.